来源：金融界 天臣国际医疗科技股份有限公司的主营业务是专注于高端外科手术吻合器研发创新和生产销售。公司的 主要产品是腔镜吻合器类、管型吻合器类、线型切割吻合器类、荷包吻合器类、线型缝合吻合器类。公 司曾获得"苏州市级智能车间——微创外科吻合器智能制造车间"称号。 最新一期业绩显示，2025年一季报，公司实现营业收入6584.61万元，同比9.34%；净利润1318.67万 元，同比16.16%，销售毛利率58.46%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天臣医疗58.0360.085.4531.18亿行业平均 55.1550.114.80115.74亿行业中值37.4836.822.6955.61亿1九安医疗11.0711.200.87186.87亿2英科医疗 14.0715.171.25222.33亿3新华医疗15.9114.751.30101.98亿4振德医疗16.1515.221.0358.62亿5山东药玻 16.2116.261.86153.29亿6奥美医疗16.3215.991.6858.96亿7康德莱17.1917.201.4237.04亿8九强生物 17.5016.272 ...

Company Overview - Tianchen Medical closed at 32.75 yuan, up 2.99%, with a rolling PE ratio of 49.47, marking a new low in 1103 days, and a total market value of 2.658 billion yuan [1] - The company specializes in the research, innovation, production, and sales of high-end surgical anastomosis devices, including various types of endoscopic and linear cutting anastomosis devices [1] - As of the first quarter of 2025, seven institutions held shares in Tianchen Medical, with a total holding of 4.481 million shares valued at 0.85 million yuan [1] Financial Performance - For the first quarter of 2025, Tianchen Medical reported revenue of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, up 16.16%, with a gross profit margin of 58.46% [1] Industry Comparison - The average PE ratio for the medical device industry is 52.06, with a median of 37.22, placing Tianchen Medical at the 87th position within the industry [1] - The industry average PE ratio is 52.06, while the median is 37.22, indicating that Tianchen Medical's PE ratio is below the industry average but above the median [2]